![Understanding Clinical Studies: Obtaining Approval, Registering the Study, and Reporting the Results | AJE Understanding Clinical Studies: Obtaining Approval, Registering the Study, and Reporting the Results | AJE](https://www.aje.com/dist/img/arc/Researcher-conducting-clinical-studies.jpg)
Understanding Clinical Studies: Obtaining Approval, Registering the Study, and Reporting the Results | AJE
![Clinical validation of deep learning algorithms for radiotherapy targeting of non-small-cell lung cancer: an observational study - The Lancet Digital Health Clinical validation of deep learning algorithms for radiotherapy targeting of non-small-cell lung cancer: an observational study - The Lancet Digital Health](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/17fcac0e-856d-45cb-aac3-1db2c194024f/gr1.jpg)
Clinical validation of deep learning algorithms for radiotherapy targeting of non-small-cell lung cancer: an observational study - The Lancet Digital Health
![De-identifying Spanish medical texts - named entity recognition applied to radiology reports | Journal of Biomedical Semantics | Full Text De-identifying Spanish medical texts - named entity recognition applied to radiology reports | Journal of Biomedical Semantics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13326-021-00236-2/MediaObjects/13326_2021_236_Fig1_HTML.png)
De-identifying Spanish medical texts - named entity recognition applied to radiology reports | Journal of Biomedical Semantics | Full Text
![Integrated Safety Analysis of 24-Week Data From Three Phase 2 and One Phase 3 Clinical Trial of Bulevirtide Monotherapy Given at 2- or 10-mg Dose Level for Treatment of Chronic Hepatitis Delta Integrated Safety Analysis of 24-Week Data From Three Phase 2 and One Phase 3 Clinical Trial of Bulevirtide Monotherapy Given at 2- or 10-mg Dose Level for Treatment of Chronic Hepatitis Delta](https://www.natap.org/2022/images/070122/070122-5/0701221.gif)